Atara Biotherapeutics Inc

Biotech Stocks Healthcare Stocks

$11.48

+0.31 (+2.78%)

As of Jun 30, 10:43 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 2 20%

Sell 1 10%

Price Target

Analyst Price Target -38.7% upside

Low Target $5.84

Average Target $7.04

High Target $9.41

Current Price $11.48

Current
$11.48

Target
$7.04

$5.84 $7.04 avg $9.41

Scenario Analysis

Bear Case

$5.84

-49.1%

Low target

Base Case

$7.04

-38.7%

Avg target

Bull Case

$9.41

+-18.0%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$19.15

-40.0% from high

52-Week Low

$3.92

+192.9% from low

Target vs 52W High

$7.04

-63.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%